Skip to main content

Table 6 FNA performance per cytology group

From: The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes

Performance on Cytology Malignant (n = 24)
Genetic alteration Histology malignant (n = 24) Histology benign (n = 0)
Positive 14 0
Negative 10 0
  1. Sensitivity, 58 % (37–78); Specificity, NA% (NA); PPV, NA% (NA); NPV, NA% (NA), prevalence of malignant lesions, 100 %. Estimated performance when malignancy is prevalent at 95 %: PPV, NA% (NA); NPV, NA% (NA)